Induced Pluripotent Stem Cells A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery

被引:18
|
作者
Chang, Chia-Yu [1 ,2 ]
Ting, Hsiao-Chien [1 ]
Liu, Ching-Ann [1 ,2 ]
Su, Hong-Lin [3 ]
Chiou, Tzyy-Wen [4 ]
Harn, Horng-Jyh [1 ,5 ,6 ]
Lin, Shinn-Zong [1 ,7 ]
机构
[1] Buddhist Tzu Chi Med Fdn, Bioinnovat Ctr, Hualien, Taiwan
[2] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan
[3] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan
[4] Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan
[5] Buddhist Tzu Chi Gen Hosp, Dept Pathol, Hualien, Taiwan
[6] Tzu Chi Univ, Hualien, Taiwan
[7] Buddhist Tzu Chi Gen Hosp, Dept Neurosurg, Hualien, Taiwan
关键词
Neurodegenerative disease; induced pluripotent stem cells (iPSCs); disease modeling; neuronal differentiation; mechanism study; drug screening; SPINAL MUSCULAR-ATROPHY; FAMILIAL ALZHEIMERS-DISEASE; MIDBRAIN DOPAMINE NEURONS; MOTOR-NEURONS; HUMAN ES; DIRECTED DIFFERENTIATION; CEREBRAL ORGANOIDS; GENETIC CORRECTION; SELF-ORGANIZATION; IPSCS REVEALS;
D O I
10.1177/0963689718775406
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Many neurodegenerative diseases are progressive, complex diseases without clear mechanisms or effective treatments. To study the mechanisms underlying these diseases and to develop treatment strategies, a reliable in vitro modeling system is critical. Induced pluripotent stem cells (iPSCs) have the ability to self-renew and possess the differentiation potential to become any kind of adult cell; thus, they may serve as a powerful material for disease modeling. Indeed, patient cell-derived iPSCs can differentiate into specific cell lineages that display the appropriate disease phenotypes and vulnerabilities. In this review, we highlight neuronal differentiation methods and the current development of iPSC-based neurodegenerative disease modeling tools for mechanism study and drug screening, with a discussion of the challenges and future inspiration for application.
引用
收藏
页码:1588 / 1602
页数:15
相关论文
共 50 条
  • [31] Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19
    Nolasco, Patricia
    Borsoi, Juliana
    Moraes, Carolina Borsoi
    Freitas-Junior, Lucio H.
    Pereira, Lygia Veiga
    GENETICS AND MOLECULAR BIOLOGY, 2020, 44 (01) : 1 - 8
  • [32] Modeling Catecholaminergic Polymorphic Ventricular Tachycardia Using Human Induced Pluripotent Stem Cells: A Promising Tool for Drug Discovery
    Sasaki, Kenichi
    Makiyama, Takeru
    Yoshida, Yoshinori
    Itoh, Hideki
    Kawamura, Mihoko
    Sumitomo, Naokata
    Miura, Masaru
    Harita, Takeshi
    Nishiuchi, Suguru
    Hayano, Mamoru
    Yamamoto, Yuta
    Wurivanghai, Yimin
    Chen, Jiarong
    Kamakura, Tsukasa
    Hattori, Tetsuhisa
    Ohno, Seiko
    Horie, Minoru
    Yamanaka, Shinya
    Kimura, Takeshi
    CIRCULATION, 2013, 128 (22)
  • [33] Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1
    Berenger-Currias, Noemie
    Martinat, Cecile
    Baghdoyan, Sandrine
    CELLS, 2023, 12 (04)
  • [34] Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review
    Kenyi Saito-Diaz
    Nadja Zeltner
    Clinical Autonomic Research, 2019, 29 : 367 - 384
  • [35] Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review
    Saito-Diaz, Kenyi
    Zeltner, Nadja
    CLINICAL AUTONOMIC RESEARCH, 2019, 29 (04) : 367 - 384
  • [36] Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease
    Ooi, Lezanne
    Sidhu, Kuldip
    Poljak, Anne
    Sutherland, Greg
    O'Connor, Michael D.
    Sachdev, Perminder
    Muench, Gerald
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (01) : 103 - 111
  • [37] Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease
    Ooi, Lezanne
    FASEB JOURNAL, 2013, 27
  • [38] Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s disease
    Lezanne Ooi
    Kuldip Sidhu
    Anne Poljak
    Greg Sutherland
    Michael D. O’Connor
    Perminder Sachdev
    Gerald Münch
    Journal of Neural Transmission, 2013, 120 : 103 - 111
  • [39] Using induced pluripotent stem cells for drug discovery in arrhythmias
    Teles, Diogo
    Fine, Barry M.
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (07) : 827 - 840
  • [40] The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing
    Lingqun Ye
    Xuan Ni
    Zhen-Ao Zhao
    Wei Lei
    Shijun Hu
    Journal of Cardiovascular Translational Research, 2018, 11 : 366 - 374